is vyvanse a glp-1 Agonist for Binge Eating Disorder: Evidence and Safety GLP-1, Vyvanse & Addiction: Understanding

Obesity drugs have another superpower: taming inflammation

How to manage it: Eat smaller, more frequent meals to avoid overwhelming your digestive system

A simple record of dose changes, meal timing, and digestive symptoms may help you and your healthcare professional understand what adjustments could improve your experience

There is no officially confirmed release date

A comprehensive analysis of 43,365 individuals from two US healthcare databases indicated that GLP-1 RAs do not elevate the risk of pulmonary aspiration during upper gastrointestinal endoscopy in patients with T2DM when compared to SGLT-2 inhibitors, yielding a pooled risk ratio of 0.98 (95% CI, 0.73 to 1.31) among GLP-1 RA users